arrow
返回
D

David Planchard

gustave roussy

87H指数
987论文数
5.1W被引数
收录论文 264
发表时间
Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies晚期非小细胞肺癌的靶向治疗:新的生物标志物和治疗策略
err2026-09-06
err0
PREAI
errLizza E L Hendriks; Jessica J Lin; Daniel S W Tan; Fabian Acker; Francesca R Ogliari; May-Lucie Meyer; David Planchard; Martin Reck
err分享
err收藏
Efficacy of Alectinib for ALK-positive NSCLC According to Tumor Burden and Body Mass Index: a Pooled Analysis of the Randomized Phase III Trials ALEX and J-ALEX根据肿瘤负荷和体重指数评估阿来替尼对ALK阳性NSCLC的疗效:ALEX和J-ALEX随机III期试验的合并分析
err2026-06-05
err0
errOAAI
errMarco Tagliamento; Marco Bruzzone; Eva Blondeaux; Filippo Dall’Olio; Mihaela Aldea; Carlo Genova; Arianna Marinello; Jordi Remon; Lizza E.L. Hendriks; Lucia Del Mastro; David Planchard; Fabrice Barlesi; Matteo Lambertini; Benjamin Besse
err分享
err收藏
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumorsBeamion PANTUMOR-1: Zongertinib二线临床试验的试验依据与设计,用于HER2过表达/扩增或HER2突变的实体瘤
err2026-03-04
err0
PREAI
errAlison M. Schram; John J. Park; Antoine Italiano; Shigehisa Kitano; Ye Guo; Jin Li; Philippe L. Bedard; Cedric van Marcke; Ryo Ko; Lukas Lunger; Daniel M. Klotz; Jo Hussain; Daniela Maier; Damijan Erzen; David Planchard; Hans Prenen; Timothy D. Clay; Joon O. Park; Hyung-Don Kim; Alberto Hernando-Calvo; Yuta Maruki; Mariano Ponz-Sarvise; Ecaterina Dumbrava
err分享
err收藏
err分享
err收藏
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial曲妥珠单抗德鲁替康在HER2过表达的非小细胞肺癌患者中的疗效:开放标签、多中心、Ⅰb期DESTINY-Lung03试验第一部分的结果
err2025-12-23
err0
errOAAI
errDavid Planchard; Hye Ryun Kim; Thatthan Suksombooncharoen; Rubi Li; Diego Cortinovis; Ji-Youn Han; Jens Samol; Yotsawaj Runglodvatana; Kang-Yun Lee; Gee-Chen Chang; Chun-Hui Lee; Dariusz Kowalski; Stephanie P.L. Saw; Yiqing Huang; Gerrina Ruiter; Myung-Ju Ahn; Tsung-Ying Yang; Cheng-Ta Yang; Aumkhae Sookprasert; Erica C. Nakajima
err分享
err收藏
The Rechallenge Benefit Score: A Clinical Decision Tool for Patients Progressing After Immunotherapy.再挑战获益评分:一种用于免疫疗法后进展患者临床决策的工具。
err2025-11-15
err0
PREAI
errCaroline Plazy; Mohamed Boussena; Linh Nguyen Phuong; Jean Baptiste Assié; Emmanuel Grolleau; Valerie Gounant; Chantal Decroisette; Eric Dansin; Catherine Daniel; Etienne Giroux Leprieur; David Planchard; Mariona Riudavets; Anthony Canellas; Youssef Oulkhouir; Maurice Pérol; Anne-Claire Toffart; Sebastien Benzekry; Elisa Gobbini
err分享
err收藏
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort studyEGFR突变晚期非小细胞肺癌患者在接受一线奥希替尼治疗后,接受卡铂联合培美曲塞二线治疗的实际疗效:一项国际多中心队列研究
err2025-10-16
err0
PREAI
errIgor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano
err分享
err收藏
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC奥希替尼联合化疗在EGFR突变型晚期非小细胞肺癌中的生存情况
err2025-10-01
err5
PREAI
errJanne, Pasi A.; Planchard, David; Kobayashi, Kunihiko; Yang, James Chih-Hsin; Liu, Ying; Valdiviezo, Natalia; Kim, Tae Min; Jiang, Liyan; Kagamu, Hiroshi; Yanagitani, Noriko; Wang, Jialei; Biswas, Bivas; Poltoratskiy, Artem; Neron, Yeni; Rojas, Carlos; Koubkova, Leona; Escriu, Carles; Ezeife, Doreen A.; Mann, Helen; Armenteros-Monterroso, Elena; Rukazenkov, Yuri; Lee, Chee Khoon
err分享
err收藏
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较(FRONT-BRAF):一项多中心、回顾性队列研究
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
err分享
err收藏
The impact of dual cannabis and tobacco smoking in young patients with lung cancer: results from the prospective “Environment and Lung Cancer” study年轻肺癌患者中双重吸食大麻和烟草的影响:来自前瞻性“环境与肺癌”研究的结果
errCHEST
IF8.6
err2025-09-24
err0
PREAI
errP. Pradère; A. Marinello; D. Vasseur; C. Naltet; S. Moaca; J. Le Pavec; M.R. Ghigna; V. De Montpreville; J. Adam; L. Lacroix; F. Ben Sallem; C. Caramella; D. Planchard; O. Mercier; M. Aldea; J.C. Alvarez
err分享
err收藏
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosisSAFIR02-Lung队列中肺腺癌的分子分析揭示了新的与转移相关的染色体拷贝数改变,包括频繁的突变特异性KRAS等位基因失衡,并将CDKN2A纯合子缺失鉴定为不良预后的独立生物标志物。
err2025-09-11
err0
PREAI
errAbderaouf Hamza; Pierre Gestraud; Maryam Karimi; Alicia Tran-Dien; Laurène Syx; Sophie Vacher; Quentin Peretti; Ludovic Lacroix; Valery Attignon; Isabelle Soubeyran; Pascal Jézéquel; David Planchard; Samia Melaabi; Trenton Dailey-Chwalibóg; Marta Jimenez; Stefan Michiels; Nicolas Servant; Christophe Le Tourneau; Nicolas Girard; Fabrice André; Benjamin Besse; Maud Kamal; Fabrice Barlesi; Ivan Bièche
err分享
err收藏
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer最终分析结果和患者报告结局来自DESTINY-Lung02——一项关于曲妥珠单抗德鲁替康在HER2突变型转移性非小细胞肺癌患者中的剂量盲法、随机、II期研究
err2025-07-30
err0
PREAI
errPasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Kyle Dunton; Ahmed Ali; Koichi Goto
err分享
err收藏
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers与晚期癌症生存相关的肠道功能障碍的替代标志物
err2025-04-06
err0
errOAAI
errRoxanne Birebent; Damien Drubay; Carolina Alves Costa Silva; Federica Marmorino; Giacomo Vitali; Gianmarco Piccinno; Yoan Hurtado; Adele Bonato; Lorenzo Belluomini; Meriem Messaoudene; Bertrand Routy; Marine Fidelle; Gerard Zalcman; Julien Mazieres; Clarisse Audigier-Valette; Denis Moro-Sibilot; François Goldwasser; Arnaud Scherpereel; Hervé Pegliasco; François Ghiringhelli; Anna Reni; Fabrice Barlesi; Laurence Albiges; David Planchard; Stéphanie Martinez; Benjamin Besse; Nicola Segata; Chiara Cremolini; Laurence Zitvogel; Valerio Iebba; Lisa Derosa
err分享
err收藏
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)简报:循环肿瘤DNA下一代测序在晚期肺鳞癌患者中的临床实用性(SQUIN)
err2025-02-14
err0
PREAI
errMiguel García-Pardo; Marta García de Herreros; Juan Carlos Laguna; Teresa Gorría; Yolanda Lage; Ana Gómez; Mª Eugenia Olmedo; Pilar Garrido; Víctor Manuel Albarran-Artahona; Ainara Arcocha; Cristina Teixido; Noemí Reguart; Alejandro Navarro; Edouard Auclin; Mike S Nahorski; Karen Howarth; David Planchard; Benjamin Besse; Natasha B. Leighl; Laura Mezquita
err分享
err收藏
err分享
err收藏
err分享
err收藏
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
err2024-12-01
err1
PREAI
errParisi, Claudia; Abdayem, Pamela; Tagliamento, Marco; Besse, Benjamin; Planchard, David; Remon, Jordi; Minuti, Gabriele; Cappuzzo, Federico; Barlesi, Fabrice
err分享
err收藏
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer
err2024-11-28
err0
errOAAI
errDall'Olio, Filippo G.; Zrafi, Wael Salem; Blampey, Quentin; Danlos, Francois-Xavier; Roulleaux-Dugage, Matthieu; Roman, Gabriel; Naltet, Charles; Cournede, Paul-Henry; Gautheret, Daniel; Aldea, Mihaela; Planchard, David; Barlesi, Fabrice; Marabelle, Aurelien; Hulett, Tyler; Chaput-Gras, Nathalie; Besse, Benjamin
err分享
err收藏